Your browser doesn't support javascript.
loading
Cannabidiol-drug interaction in cancer patients: A retrospective study in a real-life setting.
Guedon, Marie; Le Bozec, Antoine; Brugel, Mathias; Clarenne, Justine; Carlier, Claire; Perrier, Marine; Laurent, Maëliss; Hettler, Dominique; Mongaret, Céline; Bouché, Olivier; Slimano, Florian.
Afiliação
  • Guedon M; Department of Pharmacy, CHU Reims, F-51100, Reims, France.
  • Le Bozec A; Oncology Day-Hospital, CHU Reims, F-51100, Reims, France.
  • Brugel M; Department of Gastroenterology and Digestive Oncology, CHU Reims, F-51100, Reims, France.
  • Clarenne J; Department of Pharmacy, CHU de Reims, BIOs, Université de Reims Champagne-Ardenne, F-51100, Reims, France.
  • Carlier C; Oncology Day-Hospital, CHU Reims, F-51100, Reims, France.
  • Perrier M; Department of Gastroenterology and Digestive Oncology, CHU Reims, F-51100, Reims, France.
  • Laurent M; Department of Pharmacy, CHU Reims, F-51100, Reims, France.
  • Hettler D; Department of Pharmacy, CHU Reims, F-51100, Reims, France.
  • Mongaret C; Department of Pharmacy, CHU de Reims, BIOs, Université de Reims Champagne-Ardenne, F-51100, Reims, France.
  • Bouché O; Oncology Day-Hospital, CHU de Reims, BioSpecT, Université de Reims Champagne-Ardenne, F-51100, Reims, France.
  • Slimano F; Department of Pharmacy, CHU de Reims, BioSpecT, Université de Reims Champagne-Ardenne, F-51100, Reims, France.
Br J Clin Pharmacol ; 89(7): 2322-2328, 2023 07.
Article em En | MEDLINE | ID: mdl-36849134

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Canabidiol / Neoplasias Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Canabidiol / Neoplasias Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França